![Bradley Glover](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Bradley Glover
Chairman at
CHIMERIC THERAPEUTICS LIMITED
Net worth: 5 246 $ as of 29/06/2026
Profile
Bradley Glover is Non-Executive Chairman at Chimeric Therapeutics Ltd. (Australia) since 2026.
Former roles include Chief Operating Officer at Imugene Ltd. from 2023 to 2026, Chief Operating Officer & Executive Vice President at Celularity, Inc. from 2022 to 2023, Chief Technology Officer & Executive Vice President at Celularity, Inc., and Vice President-Corporate Development at Kite Pharma, Inc. Education includes an undergraduate degree from the University of California San Diego, a doctorate from The University of Colorado, and an MBA from the Rady School of Management at UC San Diego.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
IMUGENE LTD 0.02% | 29/06/2025 | 65,844 ( 0.02% ) | 5 246 $ | 29/06/2026 |
Bradley Glover active positions
| Companies | Position | Start |
|---|---|---|
| CHIMERIC THERAPEUTICS LIMITED | Chairman | 15/02/2026 |
Former positions of Bradley Glover
| Companies | Position | End |
|---|---|---|
| IMUGENE LIMITED | Chief Operating Officer | 01/01/2026 |
| CELULARITY INC. | Chief Operating Officer | 30/05/2023 |
Celularity, Inc. (United States)
 Celularity, Inc. (United States) Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company which produces allogeneic cells and tissues from postpartum placenta | Chief Tech/Sci/R&D Officer | - |
| KITE PHARMA INC | Corporate Officer/Principal | - |
Training of Bradley Glover
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
3
1st degree connections
8
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 8 |
|---|---|
Imugene Ltd.
 Imugene Ltd. BiotechnologyHealth Technology Operates as a a clinical stage immuno-oncology company | Health Technology |
University of California San Diego
 University of California San Diego Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of Colorado
 The University of Colorado Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Kite Pharma, Inc.
 Kite Pharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biotechnology company which engages in the development of novel cancer immunotherapeutic products | Health Technology |
Rady School of Management at UC San Diego
 Rady School of Management at UC San Diego Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Celularity, Inc. (United States)
Celularity, Inc. (United States) Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company which produces allogeneic cells and tissues from postpartum placenta | Commercial Services |
Chimeric Therapeutics Ltd. (Australia)
 Chimeric Therapeutics Ltd. (Australia) BiotechnologyHealth Technology Develops cell therapies for the tumors | Health Technology |
Celularity, Inc.
 Celularity, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical stage biotechnology company that discovers cancer sub-types and therapeutic options for cancer patients | Commercial Services |
- Stock Market
- Insiders
- Bradley Glover
